Mr. James Lee reports

HEALWELL AI EXPANDS GLOBAL FOOTPRINT WITH FIRST AI IMPLEMENTATION IN MIDDLE EAST AND GROWING ENTERPRISE ADOPTION ACROSS CANADA AND THE UNITED STATES

Healwell AI Inc. has won its first contract to deliver AI (artificial intelligence) solutions in the Middle East to a major governmental health system that is already part of the Orion Health network. The company has had continued commercial momentum and adoption of its AI solutions across health care systems in North America.

This milestone represents a significant step in Healwell's global expansion strategy. With active deployments now spanning Canada, the United States and the Middle East, Healwell has established contracted revenue across multiple health care systems and continues to scale adoption of its AI-driven solutions beyond life sciences and directly into front-line care delivery environments.

Active deployments across core AI solutions

Healwell is currently deploying its core AI solutions across the following health care systems:

• Smart Search (Middle East): Healwell has signed its first contract to deliver AI solutions in the Middle East, marking entry into a new geographic market and reinforcing the global applicability of its clinically validated AI platform.
• Smart Identify (United States): Healwell is actively delivering a patient identification solution within a U.S. health care environment, supporting improved patient matching, data integrity and continuity of care.
• Smart Search (Canada): The company has signed a contract to deploy its Smart Search solution within a provincial health care system in Canada, enhancing clinical information retrieval and workflow efficiency.
• Smart Summary (Canada): Healwell has successfully delivered Smart Summary into a Canadian clinical environment, enabling automated generation of structured, AI-powered summaries designed to reduce clinician burden and improve data usability.

With these deployments, Healwell's AI solutions have now been used in a number of health care systems outside of life sciences. The company is actively deploying at least one instance of each of its core AI solutions across its customer base, demonstrating both platform maturity and real-world scalability.

Dr. Alexander Dobranowski, president of Healwell AI, commented: "The recent success outside of North America is strong validation that our strategy of integrating our clinically validated AI technology across our software health care relationships is working in practice, not just in theory. Our AI suite of products is now actively employed or contracted in multiple health care environments across Canada, North America and now the Middle East. We see a growing pipeline of opportunities to add value to our existing customers, and the success of our initial pilots gives us confidence in the value we are creating to the health care system."

Building enterprise AI infrastructure for health care

Healwell continues to expand its AI-as-a-service model, embedding clinically validated artificial intelligence directly into existing health care software relationships and operational workflows. Current engagements include initiatives supporting patient identity management, automated clinical documentation, intelligent information retrieval and population health analytics.

The company reports a growing pipeline of opportunities to expand within existing customers and health care systems across Canada, the United States, Australian, New Zealand, the United Kingdom and the Middle East as initial pilot deployments transition into broader enterprise conversations.

James Lee, chief executive officer of Healwell AI, commented: "The last three months have been transformational for Healwell AI and you can see our strategy succeeding in real time. Through simplifying our product offering, integrating our platforms, and focusing on clinical validation and trust, we are building strong momentum for 2026 and beyond. We can provide genuine population intelligence to all stakeholders within a health care system; and, while the adoption cycle is still in its infancy, the future is clear and we are increasingly excited about the opportunities ahead of us."

About Healwell AI Inc.

Healwell is a health care artificial intelligence company focused on preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practice, and ultimately help improve patient health outcomes. Healwell is executing a strategy centred on developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the OTC (over-the-counter) exchange under the symbol HWAIF.

We seek Safe Harbor.